martes, 15 de septiembre de 2020

Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection Using Rapid Immunoassays | NLM

Disaster Information Management Research Center | NLM

Disaster Information and Emergency Response

09/11/2020 12:00 AM EDT


Source: World Health Organization (WHO). Published: 9/11/2020. Acknowledging the inadequacy of current data on the performance and operational utility of tests using a lateral flow immunoassay (also called an RDT) that gives results in < 30 minutes, this nine-page document seeks to provide guidance to countries on considerations for integration into COVID-19 outbreak management programs. (PDF)

No hay comentarios: